Eli Lilly cuts insulin prices up to 70% amid pressure to slash costs
(NEW YORK) -- Eli Lilly will cut the price of its most commonly prescribed insulin products by 70% and expand a program that caps patient costs at $35 per month, the company said on Wednesday."While the current healthcare system provides access to insulin for... Read More.
